Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Narcolepsy

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.

Sleep-Wake Cycles

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prototype-based sleep micro-structure learning for explainable and robust multimodal recognition of sleep-related conditions.

Research square·2026

Same author

Introduction of novel objects to the home cage of mice repeatedly disturbs sleep for seven days with minimal stress induction.

Npj biological timing and sleep·2026

Same author

Wheel Running in Digital Ventilated Cages<sup>®</sup> Is Impaired in a Model of Cancer-induced Bone Pain.

In vivo (Athens, Greece)·2025

Same author

Synergistic Impact of Sleep Disturbance and Social Isolation in Adult but Not Adolescent Female Mice.

Journal of sleep research·2025

Same author

Probability estimation of narcolepsy type 1 in DTA mice using unlabeled EEG and EMG data.

Sleep advances : a journal of the Sleep Research Society·2025

Same author

International Union of Basic and Clinical Pharmacology. CXX. γ-Hydroxybutyrate protein targets in the mammalian brain-beyond classic receptors.

Pharmacological reviews·2025

Search research articles

Related Experiment Video

Updated: Oct 29, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Narcolepsy Type I as an autoimmune disorder.

Birgitte Rahbek Kornum¹

¹Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.

Handbook of Clinical Neurology

|July 9, 2021

Summary

Narcolepsy Type 1 may be an autoimmune disease targeting brain cells. While T cells are implicated, their presence and role in the brain require further investigation for definitive autoimmune classification.

Keywords:

Autoantibodies Autoimmune Hypocretin Immune therapy Narcolepsy Orexin Pathogenesis T cells

More Related Videos

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Published on: October 6, 2023

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Oct 29, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Published on: October 6, 2023

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Area of Science:

Neuroimmunology
Autoimmune Diseases

Background:

Narcolepsy Type 1 (NT1) is increasingly suspected to be an autoimmune disorder.
Evidence suggests immune system involvement, potentially targeting hypocretin/orexin neurons.

Purpose of the Study:

To evaluate the evidence supporting the autoimmune hypothesis in Narcolepsy Type 1.
To discuss the role of T cells and the challenges in classifying NT1 as a definitive autoimmune disease.

Main Methods:

Review of genetic and epidemiological data.
Analysis of autoantibody and T cell findings in NT1 patients.
Discussion of current research limitations.

Main Results:

Autoantibodies are inconsistently detected in NT1 patients.
T cells targeting hypocretin/orexin neurons are found in NT1 patients, but their presence and pathogenicity in the hypothalamus are unconfirmed.
Immunomodulatory treatments have shown limited success.

Conclusions:

NT1 shows strong indicators of being an autoimmune disease, but definitive criteria are not yet fully met.
Further research into the precise role of the immune system in NT1 pathogenesis is crucial.
Understanding the immune mechanisms is key for developing effective treatments.